Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CinClare: Capecitabine with or without Irinotecan in Rectal Cancer
NCT02605265Phase 3Completed
- Sponsor
- Fudan University
- Start
- Oct 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irinotecan in rectal cancer, sponsored by Fudan University. Started Oct 2015; status: completed.
02
Drugs
irinotecan
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02605265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605265.